Product Safety Recalls

Product Recall Tracker

ZILEUTON Recall D-1150-2022

Description: Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16

ZILEUTON Recall D-1150-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1150-2022
Event ID90415
BrandZILEUTON
Generic NameZILEUTON
ManufacturerZILEUTON
Original Package?1
Active SubstanceZILEUTON
Drug RouteORAL
DistributionProduct was distributed to 10 wholesalers/distributors and one mail order account who may have further distributed the product nationwide.
Quantity3,216 bottles
Recall ReasonFailed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.
Drug ClassificationClass II
Drug Code Info20220622
Product NDC68180-169
Product NUIN0000175956 N0000175955 N0000008683
Pharma Class (PE)Decreased Leukotriene Production [PE]
Pharma Class (EPC)5-Lipoxygenase Inhibitor [EPC]
Recall Initiation Date20220610
Report Date20220622
Classification Date20220615
AddressHarborplace Tower111 S Calvert St Fl 21st
Baltimore, MD 21202-6174
United States
Recalling FirmLupin Pharmaceuticals Inc.
Initial Notification Letter
Unique Ingredient IdentifierV1L22WVE2S
Drug Application NumberANDA211972
Structured Product Labeling (SPL ID)5ccc51b9-399b-4c7e-b2e4-1bde256a0aee
Structured Product Labeling (SPL Set ID)cf392f79-2276-4fe1-8fa8-74afd5150f73
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.